Skip to Content

Xenazine Approval History

  • FDA approved: Yes (First approved August 15th, 2008)
  • Brand name: Xenazine
  • Generic name: tetrabenazine
  • Company: Prestwick Pharmaceuticals, Inc.
  • Treatment for: Huntington’s Chorea

Xenazine (tetrabenazine) is a selective and reversible centrally-acting dopamine depleting drug indicated for the treatment of chorea associated with Huntington's disease.

Development History and FDA Approval Process for Xenazine

DateArticle
Aug 15, 2008Approval Xenazine (Tetrabenazine) Approved by FDA for Patients with Chorea Associated with Huntington's Disease
Dec  7, 2007FDA Advisory Committee Votes Unanimously to Recommend Approval of Tetrabenazine for Chorea Associated With Huntington Disease
Mar 31, 2006Prestwick Pharmaceuticals Receives FDA Approvable Letter for Xenazine (Tetrabenazine) for Treatment of Chorea Associated with Huntington's Disease

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide